Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Clascoterone and Oxandrolone Interaction: Monitor | Peptide Database

Compound Profiles Clascoterone Topical Androgen Receptor Inhibitor | Acne & Hair Loss Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Clascoterone

Topical Androgen Receptor Inhibitor | Acne & Hair Loss

Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).

Oxandrolone

Oral Anabolic Steroid | Lean Mass & Recovery

Oxandrolone exerts its anabolic effects primarily through binding to the intracellular androgen receptor (AR), promoting nitrogen retention and protein synthesis in skeletal muscle tissue. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, which means it does not cause estrogen-mediated water retention or gynecomastia.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Clascoterone with Oxandrolone?

Yes, but with caution. Both Clascoterone and Oxandrolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.

Is Clascoterone and Oxandrolone safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, teratogenic. Monitor accordingly.

What are the interactions between Clascoterone and Oxandrolone?

Both Clascoterone and Oxandrolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time Clascoterone and Oxandrolone?

Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and Oxandrolone has a half-life of ~9-10 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Why is VIP rarely used clinically if research shows such promise?

VIP's extremely short 1-2 minute half-life makes it impractical for routine clinical use - requiring constant infusions or multiple daily injections. Stabilized analogs (like stearyl-Nle17-VIP) are 100-fold more potent but rarely available outside research settings. Limited commercial development has restricted clinical availability despite strong research foundation.

Source: peptide-db.com ↗

Research Indications

Drostanolone propionate was FDA-approved for the treatment of advanced, inoperable breast cancer in postmenopausal women. Its anti-estrogenic properties provided tumor-suppressive effects in hormone-receptor-positive breast cancers. This indication has been superseded by modern selective estrogen receptor modulators and aromatase inhibitors, and pharmaceutical production has been discontinued. Masteron is primarily used during cutting phases and pre-contest preparation to achieve a hard, dry, and defined physique. Its anti-estrogenic and non-aromatizing properties eliminate water retention from the compound, while its androgenic effects promote muscle hardness and vascularity. Most effective when body fat is below 12-15%. At moderate doses alongside a testosterone base, Masteron can improve body composition by promoting a leaner, more vascular appearance without significant scale weight changes. Commonly used in recomposition phases where the goal is visual improvement rather than mass gain. Masteron's mild anti-estrogenic properties allow it to reduce circulating estradiol levels when stacked with aromatizable compounds like testosterone. Some users employ it specifically to minimize or eliminate the need for pharmaceutical aromatase inhibitors, which can negatively impact lipids, joint comfort, and bone mineral density.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Exemestane is administered orally as a tablet, typically 25mg. Bioavailability is approximately 40-50% and is significantly increased (by roughly 40%) when taken with a fatty meal. The 24-hour half-life supports once-daily dosing for medical indications, while bodybuilding estrogen management protocols commonly use lower doses at less frequent intervals (12.5mg EOD or 25mg E3D). Because exemestane is irreversible, the effective duration of action extends beyond the drug's plasma half-life, as aromatase activity only recovers through new enzyme synthesis. On-cycle estrogen management (conservative) 12.5mg Every other day (EOD) Oral (with food) On-cycle estrogen management (moderate) 25mg Every 3 days (E3D) On-cycle estrogen management (aggressive) TRT adjunct (low-dose) Twice weekly or as needed based on bloodwork Breast cancer treatment (medical) Once daily Oral (after a meal)

Source: peptide-db.com ↗
Side effects

Can cabergoline cause side effects if prolactin is too low?

Yes. At high doses or if dopaminergic stimulation is excessive, cabergoline can lower prolactin below optimal levels, potentially causing emotional blunting, anhedonia, or compulsive behaviors. On typical 0.25-0.5 mg twice-weekly bodybuilding doses, this is uncommon, but monitoring mood is important.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides